Vanesa Gregorc

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang et al. · The Lancet Oncology · 2020 · 621 citations · Full text

Virus Epidemiology, Medicine, Covid-19 Pandemic +12

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Kazuhiko Nakagawa, Edward B. Garon, Takashi Seto et al. · The Lancet Oncology · 2019 · 594 citations · Full text

Medicine, Pathology, Immune Checkpoint Inhibitor +5

Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer

Federico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli et al. · JNCI Journal of the National Cancer Institute · 2004 · 367 citations · Full text

Increased<i>HER2</i>Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients

Federico Cappuzzo, Marileila Varella‐Garcia, Hisayuki Shigematsu et al. · Journal of Clinical Oncology · 2005 · 366 citations · Full text

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

Giovanni Luca Ceresoli, Federico Cappuzzo, Vanesa Gregorc et al. · Annals of Oncology · 2004 · 352 citations · Full text

Non-small-cell Lung Cancer, Brain Metastases, Medicine +7